Pluristem Therapeutics CEO Zami Aberman's 2011 pay jumps 134% to $1.3M
Pluristem Therapeutics reports 2011 executive compensation
By ExecPay News
Published: March 22, 2012
Pluristem Therapeutics reported fiscal year 2011 executive compensation information on March 22, 2012.
In 2011, two executives at Pluristem Therapeutics received on average a compensation package of $1.1M, a 156% increase compared to previous year.
Average pay of disclosed executives at Pluristem Therapeutics
Zami Aberman, Chief Executive Officer, received $1.3M in total, which increased by 134% compared to 2010. 69% of Aberman's compensation, or $901K, was in stock awards. Aberman also received $383K in salary and $22K in other compensation.
Yaky Yanay, Chief Financial Officer, received a compensation package of $862K, which increased by 198% compared to previous year. 73% of the compensation package, or $629K, was in stock awards.
Pluristem Therapeutics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on March 22, 2012.